Search results
May 8, 2024 · The US Food and Drug Administration says that it takes conflicts of interest seriously. But financial entanglements with the drug industry are common among its leaders. Peter Doshi reports At his public confirmation hearing in late 2021, Robert Califf, President Biden’s nominee to lead the US Food and Drug Administration (FDA), faced pointed questions about his financial relationships with ...
May 8, 2024 · Doshi reports that nine of the FDA’s past 10 commissioners went on to work for the drug industry or serve on the board of directors of a drug company. That includes Margaret Hamburg, who led...
May 8, 2024 · Doshi reports that nine of the FDA’s past 10 commissioners went on to work for the drug industry or serve on the board of directors of a drug company. That includes Margaret Hamburg, who led FDA between 2009 and 2015, but whose story is less well known.
May 11, 2024 · This article focuses on Margaret Hamburg, who led the FDA between 2009 and 2015. “Like her colleagues, Hamburg had relationships with FDA regulated companies before and after her stint at the FDA’s helm.
May 9, 2024 · Credit: Pixabay/CC0 Public Domain An investigation published by The BMJ today raises concerns about financial entanglements between US New research reports on financial entanglements between FDA chiefs and the drug industry - miani.com
May 18, 2024 · The article focuses on Margaret Hamburg, FDA commissioner. between 2009 and 2015, who held financial interests in Renaissance Technologies (RenTec), an exclusive hedge fund managed by her husband's company. According to the. BMJ, RenTec consistently invested in FDA-regulated drug companies while Hamburg led the agency. "The facts raise concerns ...
May 2, 2024 · In this conversation, we will go #Beyondthename and delve into Dr Hamburg's ongoing achievements and experiences as she reflects on her professional journey ...
